Teva Pharmaceutical Industries Limited
TEVA
Κατάταξη σε μετοχές
#13240
Teva Pharmaceutical Industries Limited operates as a prominent global... Teva Pharmaceutical Industries Limited operates as a prominent global pharmaceutical firm, involved in the research, development, manufacturing, marketing, and distribution of generic, specialized, and biopharmaceutical products throughout North America, Europe, and other international regions. The company's diverse portfolio encompasses sterile preparations, hormonal therapies, high-potency drugs, and cytotoxic substances, supplied in a wide array of dosage forms such as tablets, capsules, injectable solutions, inhalants, oral liquids, transdermal patches, topical ointments, and creams. Furthermore, Teva develops, produces, and sells active pharmaceutical ingredients (APIs). A significant portion of its research and product development is concentrated on the central nervous system, pain management, respiratory illnesses, and oncology. Leading products for the central nervous system include Copaxone, utilized for relapsing multiple sclerosis; AJOVY, an option for migraine prevention; and AUSTEDO, prescribed for tardive dyskinesia and chorea linked to Huntington's disease. Within the respiratory domain, addressing asthma and chronic obstructive pulmonary disease, Teva offers products like ProAir, QVAR, various Digihaler and RespiClick formulations, along with BRALTUS and CINQAIR/CINQAERO. Their oncology division features treatments such as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company also collaborates with MedinCell on the creation and commercialization of multiple extended-release injectable products, including a risperidone suspension designed for individuals with schizophrenia. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Τιμή μετοχής
$41.51
Τελευταίος συγχρονισμός: 2026-10-16
Κεφαλαιοποίηση
$483.77M
Αλλαγή (1 ημέρα)
-0.85%
Αλλαγή (1 έτος)
107.47%
Χώρα
IL
Εμπόριο Teva Pharmaceutical Industries Limited (TEVA)
Κατηγορία
Healthcare
Κεφαλαιοποίηση αγοράς του Teva Pharmaceutical Industries Limited(TEVA)
Κεφαλαιοποίηση: $483.77M
Μέχρι το October 2026, η Teva Pharmaceutical Industries Limited έχει χρηματιστηριακή αξία $483.77M. Αυτό καθιστά τη Teva Pharmaceutical Industries Limited την 13240th πιο πολύτιμη εταιρεία στον κόσμο βάσει της κεφαλαιοποίησης σύμφωνα με τα δεδομένα μας. Η χρηματιστηριακή κεφαλαιοποίηση είναι η συνολική αγοραία αξία των μετοχών μιας εισηγμένης εταιρείας και χρησιμοποιείται συνήθως για να προσδιοριστεί η αξία μιας εταιρείας.
Ιστορικό κεφαλαιοποίησης αγοράς της Teva Pharmaceutical Industries Limited από 2010 έως 2026
TEVA σε σύγκριση με τα 5 πιο δημοφιλή stocks
